Gabapentin enacarbil (XP13512/GSK1838262) as an alternative treatment to dopaminergic agents for restless legs syndrome

Author: Imamura Susan   Kushida Clete  

Publisher: Informa Healthcare

ISSN: 1465-6566

Source: Expert Opinion on Pharmacotherapy, Vol.11, Iss.11, 2010-08, pp. : 1925-1932

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract